Drug firm fined $1.1B for hiding Risperdal's risks
Wednesday, April 11, 2012 - 11:01
in Psychology & Sociology
An Arkansas judge has fined Johnson & Johnson and a subsidiary more than $1.1 billion after a jury found hid risks associated with an antipsychotic drug Risperdal.